<code id='52F6FF7C78'></code><style id='52F6FF7C78'></style>
    • <acronym id='52F6FF7C78'></acronym>
      <center id='52F6FF7C78'><center id='52F6FF7C78'><tfoot id='52F6FF7C78'></tfoot></center><abbr id='52F6FF7C78'><dir id='52F6FF7C78'><tfoot id='52F6FF7C78'></tfoot><noframes id='52F6FF7C78'>

    • <optgroup id='52F6FF7C78'><strike id='52F6FF7C78'><sup id='52F6FF7C78'></sup></strike><code id='52F6FF7C78'></code></optgroup>
        1. <b id='52F6FF7C78'><label id='52F6FF7C78'><select id='52F6FF7C78'><dt id='52F6FF7C78'><span id='52F6FF7C78'></span></dt></select></label></b><u id='52F6FF7C78'></u>
          <i id='52F6FF7C78'><strike id='52F6FF7C78'><tt id='52F6FF7C78'><pre id='52F6FF7C78'></pre></tt></strike></i>

          entertainment

          entertainment

          author:explore    Page View:5
          Pregnancy and clinical trials
          Adobe

          The FDA has taken a big step in encouraging drug companies to include pregnant women in clinical trials, issuing a draft guidance outlining how to do so safely and ethically.

          Nearly 4 million women in the U.S. give birth each year, but few drugs have been approved as safe and effective to use during pregnancy. The new guidance aims to help drug companies address those information gaps “through judicious inclusion of pregnant women in clinical trials and careful attention to potential fetal risk.”

          advertisement

          Experts say it’s a sign of progress on an issue that’s long plagued pregnant women and their physicians.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          How one medical school became remarkably diverse
          How one medical school became remarkably diverse

          ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

          read more
          Medicare Advantage 2025 payments will dip, Biden administration says
          Medicare Advantage 2025 payments will dip, Biden administration says

          AdobeOverthepastfewweeks,MedicareAdvantageinsurersdemandedthattheBidenadministrationgivethemhigherpa

          read more
          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more

          AstraZeneca loses challenge to Medicare drug price negotiation

          ANDREWYATES/AFPviaGettyImagesWASHINGTON—AfederaljudgeinDelawareonFridayruledagainstAstraZenecainacas